Skip to main content
. 2017 Jan 5;27:16084. doi: 10.1038/npjpcrm.2016.84

Figure 3.

Figure 3

Prevalence of respiratory symptoms among participants with no COPD (n=3.175), COPD only (n=436) and possible ACOS, identified by either self-reported wheeze (ACIS wheeze; n=151), bronchodilator reversibility (ACOS-BDR; n=74) of both (ACOS wheeze+BDR; n=39).